Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: milton who wrote (7862)	1/22/1998 12:09:00 PM
From: Decci	Read Replies (1) \| Respond to of 14328

Milton, I have gamed this last announcement to try to understand why we have no market reaction. SBH is a $300 Billion company. That is like having a powerful sovereign government as an ally and financial insurer. I see this aggreement as validation for and precurser to Uni-Gold FDA approval. Brendan is presenting this company to a large financial institution in SF next week. I expect a favorable recommendation from them. I believe the management will continue to build this company from a PR standpoint as well as put increased numbers on the bottom line. SBH is nearly twice the size of Glaxo, and everyone gets excited when they hear GLX. I am very pleased with the effort, however, concerned about the lack of market response. In addition, watch closely for an SEC filing from December which will be fantastic news for this company, soon. OUT